Descriptive epidemiological study of head and neck cancers at a single institution in Southern Africa by Naidoo, Komeela
Descriptive epidemiological study of head and neck cancers at a single institution in 
Southern Africa. 
Dr Komeela Naidoo   
Thesis presented in partial fulfilment of the requirements for the degree of Master of Science 
in the Faculty of Clinical Epidemiology at Stellenbosch University. 
Supervisor: HM Simonds 
Co-supervisor: A. Afrogheh 
Date of award of degree: December 2019 
By submitting this thesis electronically, I declare that the entirety of the work contained 
therein is my own, original work, that I am the sole author thereof (save to the extent 
explicitly otherwise stated), that reproduction and publication thereof by Stellenbosch 
University will not infringe any third party rights and that I have not previously in its entirety 
or in part submitted it for obtaining any qualification.  
Date: 11 November 2019 
Copyright © 2019 Stellenbosch University All rights reserved 
Stellenbosch University  https://scholar.sun.ac.za
  
Abstract 
Head and Neck Cancers (HNCs) constitute a major public health concern worldwide. The 
incidence is approximately two times more in less-developed regions as compared to more 
developed regions.  The estimated incidence in sub-Saharan Africa is 27593 per 100000 with 
a cumulative risk of 0.66. We evaluated patient demographics, risk factors, tumours 
characteristics, prognostic factors, disease stage, treatment intent and treatment modality in a 
cohort of patients with HNC in Cape Town, SA.  
Records of all HNC patients that presented to Tygerberg Hospital oncology department 
between 1 January 2015 and 31 December 2017 were reviewed. The following variables were 
described: patient demographics, which include age, sex, HIV status, and socio-economic 
status as well as tumour characteristics, risk factors, treatment intent and treatment modalities.  
Data was collected from 854 patients seen between 2015 and 2017. There were 603 (71%) 
male and 251 (29%) female. The male to female ratio was 2.4:1.  The age range was 10-89 
years (median age 58 years).  Smoking was a risk factor in 737 (86.3%) and alcohol in 634 
(74.2%) of patients. Of the 167 patients with oropharyngeal primaries, 16 (9.58%) patients had 
p16 positive, 78 (46.70%) were p16 negative and the p16 status was unknown in 73 (43.7%). 
The most common site was the oral cavity (n=320) and the most common sub-site was the 
anterior tongue (n=137).  Eleven patients had two separate primaries at the time of diagnosis.  
In total, 466 patients (53.87%) presented with locally advanced, stage IVA disease. 
The median age of diagnosis, the most predominate primary site; histological subtype and stage 
at presentation were consistent with that reported in the literature. We have demonstrated that 
the majority of patients present at a late stage, with locally advanced disease.  This together 
with the predominate risk factors of smoking and alcohol consumption is a potential target for 
health campaigns and awareness programmes.  This cohort will be followed up for treatment 
outcomes and survival rates. 
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Opsomming  
Kop- en-nek kankers (KNK's) is 'n groot probleem vir die openbare gesondheid sektor. Die 
voorkoms van KNK’s is ongeveer twee keer meer in minder gegoede areas in vergelyking 
met meer ontwikkelde streke. Die geraamde voorkoms in sub-Sahara Afrika is 27 593 per 
100 000 individue met 'n kummulatiewe risiko van 0,66. Ons het die pasiënt kenmerke , 
risiko faktore, gewas kenmerke, prognostiese faktore, siekte stadium,en behandelings 
doelwitte asook die behandelings modaliteit in 'n groep pasiënte wat met KNK’s 
gediagnostiseer was geëvalueer. 
Kliniese verslae van alle KNK’s-pasiënte wat vanaf 1 Januarie 2015 tot 31 Desember 2017 
by Tygerberg-hospitaal se onkologie-afdeling gepresenteer het, is nagegaan. Die volgende 
veranderlikes is beskryf: pasiënt kenmerke, ouderdom, geslag, MIV- en sosio-ekonomiese 
status, sowel as die kanker gewas-karaktertrekke, risiko faktore, behandelings-doelwitte en 
modaliteit is geëvalueer. 
Kliniese inligting van 854 pasiënte, is nagegaan. Daar was 71% manlike en  29% vroulike 
pasiënte. Die verhouding tussen mans en vroue was 2.4:1. Die groep se ouderdom 
verspreiding was 10-89 jaar, met ‘n gemiddelde ouderdom van 58 jaar. Rook was 'n risiko 
faktor in 86,3% en alkohol in  74,2% van die pasiënte.  
In 167 pasiënte met primêre orofaryngeale kanker, was 9,58% pasiënte p16 positief, 46,70% 
was p16 negatief en in 43,7% van die pasiënte was die p16-status onbekend. Die oorwegende 
aangetasde area was die mondholte (n = 320) met die algemeenste sub-lokasie die anterior 
gedeelte van die tong (n = 137). Elf pasiënte het by hul aanvanklike presentasie, gepresenteer 
met twee afsonderlike primêre kankers. In totaal het 53,87% pasiënte gepresenteer met lokaal 
gevorderde stadium IVA-siekte. 
Die gemidelde ouderdom by diagnose, die oorheersende primêre area; histologiese subtipe en 
stadium tydens aanvanklike presentasie was in ooreenstemming met wat in die Internationale 
literatuur gemeld word. Ons het ook getoon dat die meerderheid van pasiënte presenteer met 
lokaal  gevorderde siekte en met die risiko faktore van rook en alkohol misbruik is dit 'n 
potensiële teiken vir gesondheids veldtogte en bewusmakings programme. Hierdie groep 
word ook nog tans opgevolg vir behandelings uitkomste en oorlewing syfers. 
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Descriptive epidemiological study of head and neck cancers at a single institution in 
Southern Africa. 
 
Introduction. 
 
Head and Neck Cancers (HNCs) constitute a major public health concern worldwide. There 
has been a significant increase in the global incidence of HNCs, which is increasing sharply in 
developing countries. The incidence is approximately two times more in less-developed 
regions as compared to more developed regions (2).    
The worldwide incidence is greater than 550000 cases with approximately 350000 deaths per 
annum (2).   In 2017, about 63030 new cases of oral cavity, pharyngeal and laryngeal cancer 
will occur in the USA (about 3.7% of all new cases).  An estimated 13360 deaths from HNCs 
will occur during the same period (2). 
 
The estimated incidence in sub-Saharan Africa is 27593 per 100000 with a cumulative risk of 
0.66 (1) . According to the 2014 South African National Cancer Registry, the age-standardised 
ratios were 2.01, 1.71, 1.56, 2.64, 0.36 and 0.13 per 100000 per year for males, for mouth, 
tongue, nasopharynx, larynx, lip and gum respectively and 0.80, 0.46, 0.42, 0.2, 0.15 and 0.09 
for females (3). 
The most common histological type is squamous cell carcinoma and its variants, which 
accounts for about 90% of all head and neck malignancies. Other histologic types include 
adenocarcinoma, NOS (Not Otherwise Specified), adenoid cystic carcinoma, mucoepidermoid 
carcinoma, melanoma and small cell neuroendrocrine carcinoma.  
 
Over 50% of HNCs occur in men (4).  The male to female ratio is different for each sub site. 
The male to female ratio is 3:1 for oral cavity and pharyngeal cancers.  Males are also more 
likely to have HPV-associated cancers (4). 
The incidence of HNCs increases with age, with most patients being between the ages of 50-
70. (4). Younger patients can also develop HNCs.  The younger patients are more likely to be 
of female gender with no known risk factors(4).  Younger patients often present with more 
advanced disease, which may be due to more aggressive nature of the disease or delay in 
diagnosis, and as a result have a poorer prognosis.   
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Approximately 30% of patients present with localised disease, 47% with regional disease and 
18% with distant or metastatic disease (2). The survival decreases with increasing stage of 
disease. The 5-year overall survival is 83% for localised disease, 63% for regional disease and 
38% for distant disease (2). 
Predictors of overall survival include older age, higher tumour stage and high alcohol 
consumption (8). 
 
There are numerous, well-established risk factors for the development of HNCs.  These include 
tobacco, alcohol, high-risk human papilloma virus (HR-HPV) exposure, Epstein Barr virus 
(EBV) infection, dental factors such as poor oral health, dietary deficiencies and betel leaf 
chewing. HR-HPV status is an important risk factor and prognostic factor in oropharyngeal 
lesions.   Other factors, increasing the risk, include occupational exposure (wood dust and 
nickel exposure), sun exposure (for lip squamous cell carcinoma), smokeless tobacco, cigars 
and marijuana (4).  Chronic exposure of the aero-digestive tract to these factors can result in the 
development of pre-malignant lesions of the mucosa, which can ultimately lead to invasive 
malignancy. 
 
Currently there is limited data regarding epidemiological trends of HNCs in Southern Africa. 
The aim of the current study was to evaluate and describe patient demographics, risk factors, 
tumours characteristics, prognostic factors, disease stage, treatment intent and treatment 
modality, at a single institution in Southern Africa.   This information could be used to promote 
awareness of HNCs and support disease prevention programmes.  
 
Methods and materials 
This retrospective cross-sectional study was conducted at Tygerberg Hospital (TBH) oncology 
department, Western Cape, South Africa. Ethics approval was obtained from the University of 
Stellenbosch Health Research Ethics Committee (S18/08/172) as well as Tygerberg Hospital.   
 
Records of all patients that presented between 1 January 2015 and 31 December 2017 were 
reviewed. Variables analysed were age, sex, HIV status, the Eastern Cooperative Oncology 
group (ECOG) performance status and socio-economic status.  
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The uniform patient fee schedule (UPFS) was used as a surrogate for socioeconomic status.  
This allocated category depends on the individual’s/household’s income per annum (in South 
African rands/Euros), as shown in appendix 1.  Tumours were classified according to 
anatomical site. Staging was done according to the American Joint Committee on Cancer 
(AJCC) TNM 7th edition.  
Treatment intent was described as radical or palliative.  Radical treatment modalities consisted 
of surgery, chemotherapy or radiation therapy alone or in combination. Palliative treatment 
modalities consisted of chemotherapy, radiotherapy and/or best supportive care. Surgery is 
seldom used as a treatment modality in patients with palliative intent. 
 
Data was collected from routine patient files, and entered into a customised data collection 
sheet.  Data from the data collection sheets was entered into Microsoft Excel 2013.  Statistical 
analysis was performed using Microsoft Excel. 
Results 
Data was collected from 854 patients seen between 2015 and 2017, with 865 tumours being 
reported. There were 603 (71%) males and 251 (29%) females. The male to female ratio was 
2.4:1.  The age range was 10-89 years (median age 58 years).  Table 1 shows the distribution 
of patients for each age group. 
Table 1. Age distribution of head and neck cancer patients 
Age group Number of patients (%) 
≤ 30 15 (1.76) 
31-40 20 (2.34) 
41-50 140 (16.39) 
51-60 331 (38.76) 
61-70 246 (28.81) 
71-80 82 (9.60) 
>80 20 (2.34) 
 
Smoking was a risk factor in 737 (86.3%), alcohol in 634 (74.2%) and both in 620 (72.6%) of 
patients.  Fifty-six (9%) were HIV positive, 721 (84%) were negative and 77 (7%) had 
unknown HIV status.   
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The ECOG performance status was recorded as 0 in 5 (0.59%), one in 460 (53.86%), two in 
232 (27.17%), three in 128 (14.89%), four in 27 (3.16%) and unknown in two (0.23%) patients.  
Table 2 shows uniform patient fees schedule (UPFS), which is a surrogate for the socio-
economic status of patients. The vast majority of patients had no reported income.  
Table 2. Socio-economic status of head and neck cancer patients. 
UPFS Number of patients (%) 
0 339 (39.70) 
1 403 (47.19) 
2 45 (5.27) 
3 20 (2.34) 
Medical aid 24 (2.81) 
Unknown 23 (2.69) 
 
The most common site was the oral cavity (n=320) followed by the larynx (n= 188) and the 
oropharynx (n=167). The most common sub-site was the anterior tongue (n=137) followed by 
the supraglottic larynx (n=98).  Eleven patients had two separate primaries at the time of 
diagnosis.  Appendix 2 shows the distribution of disease according to anatomical site. 
The most predominate histological type was squamous cell carcinoma (SCC), which accounted 
for 791 (92.6%) of all cases. In patients who had two synchronous primaries, both primaries 
were found to be SCCs.   
 There were 174 (20.37%) grade I or well differentiated SCCs, 409 (47.90%) grade II or 
moderately differentiated SCCs, 58 (6.79%) grade III or poorly differentiated SCCs and 150 
(17.56%) SCCs with unknown histological grade. 
Of the 167 patients with oropharyngeal primaries, 16 (9.58%) patients had p16 positive SCCs 
(p16 antibody showing nuclear and cytoplasmic positivity in more than 70% of the tumour 
cells), 78 (46.70%) were p16 negative and the p16 status was unknown in 73 (43.7%).  Three 
(18.75%) of the p16 positive oropharyngeal lesions were HPV-DNA positive using Polymerase 
Chain Reaction (PCR).  
 
Stellenbosch University  https://scholar.sun.ac.za
5 | P a g e
The majority of patients presented with locally advanced disease, 466 (53.87%) had stage IVA 
disease at presentation. Eight patients had two primaries at the time of diagnosis and both of 
these were stage IVA.   Patients with two primaries had each primary staged separately.   
Distant metastases were diagnosed in 53 patients, of which 35 had lung metastasis, 10 had 
multiple sites, two presented with bone metastasis and six patients had other sites for distant 
disease. Table 3 shows the sub-site distribution according to the TNM stage grouping. 
Table 3. The sub-site distribution according to the TNM stage grouping.  Number of patients 
n=854. Number of tumours n=865. 
Stage grouping Anatomical site Number of tumours (%) 
I Oral cavity 34 (3.93) 
Larynx 23 (2.66) 
Other 5 (0.58) 
II Oral cavity 24 (2.81) 
Larynx 13 (1.52) 
Oropharynx 8 (0.94) 
Other 8 (0.94) 
III Larynx 33 (3.86) 
Oral cavity 20 (2.34) 
Oropharynx 18 (2.10) 
Nasopharynx 8 (0.94) 
Other 13 (1.52) 
IVA Oral cavity 207 (24.24) 
Oropharynx 97 (11.36) 
Larynx 93 (10.89) 
Hypopharynx 27 (3.16) 
Salivary gland 14 (1.64) 
Sinuses 14 (1.64) 
Other 22 (2.58) 
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IVB Oropharynx 28 (3.28) 
Oral cavity 25 (2.92) 
Hypopharynx 16 (1.87) 
Larynx 11 (1.29) 
Sinuses 10 (1.17) 
Other 22 (2.58) 
   
IVC Larynx 14 (1.64) 
Oropharynx 11 (1.29) 
Unknown primary 8 (0.94) 
Hypopharynx 6 (0.70) 
Oral cavity 5 (0.58) 
Other 9 (1.05) 
   
IV Sinuses 3 (0.35) 
Base of tongue 1 (0.12) 
Other  3 (0.35) 
   
Unstaged Oral cavity 5 (0.58) 
Oropharynx 3 (0.35) 
Other 4 (0.47) 
 
Four hundred and forty nine (52.58%) patients were treated with radical/curative intent and 
405 (47.42%) received palliative treatment. Radical treatment modalities consisted of surgery, 
radiotherapy and chemotherapy, alone or in combination.  Palliative treatment consisted of 
surgery, radiotherapy, chemotherapy, combined radiotherapy and chemotherapy or best 
supportive care alone.  The radical treatment group one patient had surgery followed by 
definitive chemoradiation and one patient only received induction chemotherapy.  Four of the 
11 patients with second primaries were treated with palliative intent.   Table 4 shows the 
distribution of various treatment modalities, according to treatment intent. 
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Table 4. Treatment modalities 
Treatment intent Treatment modality Number of patients 
(%) 
Radical Surgery 325 (38.06) 
Radiotherapy 32 (3.75) 
Adjuvant radiotherapy 140 (16.39) 
Adjuvant chemoradiation 56 (6.56) 
Definitive chemoradiation 93 (10.89) 
Neoadjuvant/induction chemotherapy 31 (3.63) 
   
Palliative Surgery 1 (0.12) 
Radiotherapy 310 (36.30) 
Chemotherapy 11 (1.29) 
Chemotherapy and radiotherapy 4 (0.47) 
Best supportive care  87 (10.19) 
 
 
Discussion 
HNCs constitute a major public health concern worldwide. There has been a significant 
increase in the global incidence of HNCs, which is increasing sharply in developing countries 
(1).  Studies from South America and West Africa have shown a similar burden of disease (11, 
27, 28).  Currently there is limited data regarding epidemiological trends of HNCs in Southern 
Africa. The aim of the current study was to evaluate and describe patient demographics, risk 
factors, tumours characteristics, prognostic factors, disease stage, treatment intent and 
treatment modality at a single institution in Southern Africa, and compare them to reported 
international trends.  This information could be used to promote awareness of HNCs and 
support disease prevention programmes.  
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Eight hundred and fifty four patients were diagnosed with HNCs between 2015 and 2017, 
12.7% of all patients seen at the Radiation Oncology Department at Tygerberg Hospital during 
this period.   
The median age in this cohort was 58 years, with most patients being between the ages of 51 
and 70 years, similar to the data reported in literature (4).  Over 70% of patients were males, 
consistent with the existing reports that men are two to three times more likely to develop HNC 
(4). The male: female ratio was 2.4:1; globally this ratio varies between 2:1 to 4:1. (18) 
Smoking was a risk factor in 737 of the subjects (86.3%), and alcohol in 634 (74.2%). Both 
smoking and alcohol were co-risk factors in 620 (72.6%) of the patients. Eleven (50%) of the 
patients with HPV positive tumours also had both smoking and alcohol as risk factors.  Tobacco 
smoking and alcohol consumption are well-established major risk factors for HNCs and a 
synergistic effect of these two factors has been consistently reported (19).   
Fifty-six (9%) patients were HIV positive, 721 (84%) were HIV negative and 77 (7%) had 
unknown HIV status.  The HIV prevalence in the Western Cape was 12.6% in 2017.   The 
South African National HIV Prevalence, Incidence and Behaviour Survey in 2012 reported an 
HIV prevalence of 7.6% in individuals over 50 years of age (29). The prevalence of HIV in our 
patient group, with a median age of 58, is similar that of the nationwide prevalence in over 50 
year olds.  HIV infection increases susceptibility to opportunistic infections and virus-induced 
cancers, however, the exact mechanism of HIV promoted carcinogenesis is not known (20). 
According to the 2011 South African census, low-income households are classified as those 
with a combined annual household income of below R19200.  In this study, 56% of the patients 
fall into the low-income category.  Studies have shown an increased risk of HNCs in 
individuals of lower socioeconomic status, even after controlling for other risk factors such as 
smoking and alcohol consumption (21, 22).  In addition due to the structure of health care in South 
Africa the number of patients with low-income will be higher in this centre.  
The most common anatomical site in this study was the oral cavity (320, 37%), followed by 
the larynx (188, 21.73%) and then the oropharynx (167, 19.31%).  The most common sub-site 
was the anterior tongue, accounting for 15.84% (137) of the cases, followed by supraglottis 
11.33% (98) and the glottis 10.40% (90), in descending order of frequency.  The Surveillance, 
Epidemiology, and End Results [SEER] Programme reports that the commonest site for HNC 
is the oral tongue followed by the larynx (14).  
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Field cancerization describes the presence of premalignant fields surrounding the primary 
tumour and has been related to the high rate of local recurrence in HNCs as well as the 
development of synchronous primaries (23). Synchronous cancer is defined as two or more 
neoplasms identified simultaneously in the same patient.  It is estimated that one to six percent 
of patients diagnosed with SCC of head and neck will have a synchronous primary in the head 
and neck region (24). In this study eleven (1.3%) presented with a synchronous primary in the 
head and neck region.  
Amongst HNCs diagnosed, the most predominate histological type was SCC, which accounted 
for 791 (92.6%) of all cases. This is consistent with the incidence of SCC in the head and neck 
region, reported in the literature.    
ICON-S was a multicentre cohort study conducted in Europe and North America; they found 
73.26% of patients had HPV-positive oropharyngeal SCC (25). In this study, sixteen (9.58%) of 
oropharyngeal lesions were HPV-positive. Due to the large number of oropharyngeal primaries 
with unknown HPV status, we are unable to draw conclusions regarding the overall incidence.  
The large percentage of oropharyngeal lesions with unknown p16 status is due to the fact that 
p16 has only become a routine test in recent years.   The incidence of oropharyngeal cancer in 
males younger than 60 years of age is increasing, whereas cancers of the oral cavity and SCC 
of the lung are declining in incidence. This contrast suggests an aetiology other than tobacco 
smoking in this patient group.  In females, all three cancers are increasing in incidence, which 
indicates smoking as the major etiological factor (26).   
According to the Surveillance, Epidemiology, and End Results (SEER) database, in the United 
States 42-62% of patients with HNCs presented with locally advanced disease and 16-27% 
with distant metastases(2). An epidemiological review of head and neck patients at a university 
hospital in Brazil reported that 47.8% of patients had T3/T4 disease and 31.9% had node 
positive disease (11).  In the current study, a significant number of patients presented with locally 
advanced disease, 466 (53.87%), consistent with the data from the SEER database. The 
incidence of distant metastases was 6.21%, which is lower than that of patients presenting in 
the United States.   
The treatment intent and modality offered to patients depends on multiple factors, i.e. stage at 
presentation, performance status, co-morbidities, social circumstances as well as patient’s 
wishes.  In our patient group, 449 (52.6%) patients had treatment with radical intent and 405 
(47.4%) with palliative intent.  The majority of patients in the radical intent group had surgery 
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(72.4%) and approximately the same proportion of patients received radiotherapy as part of 
their treatment. Two hundred and twenty six patients (50.3%) received combined modality, 
including surgery, chemotherapy and radiotherapy.   
Of the patients that received palliative intent, 76.5% received radiotherapy and 21.5% were not 
fit for any treatment and received medical palliation and best supportive care.  Just less than 
half of the patients were for palliative intent; this could be due to the late stage at presentation.  
The latter could be attributed to poor socio-economic status, lack of knowledge and 
understanding, problems accessing the health services and possible other unknown factors i.e. 
genetic factors in this patient population.  
Conclusion 
In conclusion, the epidemiological factors described in this study of HNC patients in a tertiary 
hospital in Southern Africa (median age of diagnosis, the most predominate primary site, 
histological type and stage at presentation) were consistent with those reported in the.  We have 
demonstrated that the majority of patients present at a late stage, with locally advanced disease.  
This together with the predominate risk factors of smoking and alcohol consumption is a 
potential target for health campaigns and awareness programmes.  This cohort will be followed 
up for treatment outcomes and survival rates. 
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Appendix 1. 
Uniform patient fee schedule 
 
Tariff 
category 
Household gross 
income per annum 
(01/02/2001-
31/03/2017) 
Household gross 
income per annum 
(from 01/04/2017) 
Single without 
dependents gross 
income per annum 
(01/02/2001-
31/03/2017) 
Single without 
dependents gross 
income per annum 
(from 01/04/2017) 
H0- patients under the age of 18, pensioners and the unemployed  
H1 Less than 
R50 000(€3200) 
Less than R100000 
(€6400) 
Less than R36000 
(€2200) 
Less than R70000 
(€4450) 
H2 More than or equal 
to R50000 (€3200) 
but less than 
R100000 (€6400) 
More than or equal 
to R100000 (€6400) 
but less than 
R350000 (€22300) 
More than or equal 
to R36000 (€2200) 
but less than 
R72000 (€4600)  
More than or equal 
to R70000 (€4450) 
but less than 
R250000 (€16000) 
H3 More than or equal 
to R100000 (€6400) 
More than or equal 
to R350000 
(€22300) 
More than or equal 
to R72000 (€4600)   
More than R250000 
(€16000) 
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Appendix 2  
Distribution of disease according to anatomical site.  
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